GLP-1 weight loss users significantly reduce their unit volume of food purchasing (-8.6%) and more revealingly of alcohol (-14.5%).[18] More recent, less accurate, survey research on GLP-1 weight-loss drug users from September 2023 suggests the following rank order of reported decreased consumption that features a big impact to the QSR and candy industries: Fast Food (77%) Pizza restaurants (74%) Confectionery (72%) Carbonated/sugary drinks (70%) Cookies/baked products (69%) Alcohol (66%)[19] Top foods where users report an increase in consumption: Fruits and vegetables 54% Weight-loss management foods (44%) Poultry and fish (38%)[20] GLP-1 drugs, unlike bariatric surgery, appear to have a strong effect on muting intrinsic desire for compulsive (and impulsive) eating and drinking
In that spirit, weve compiled some standout statistics from recent industry activity, along with real-world examples from 2024 to 2025
347 ADH-6 stabilizes the p53 R248W mutant by interacting with the p53 core domain, preventing the formation of these aggregates
mg/kg), its effectiveness (and therapeutical application) can be extended to different organ lesions
They rationed their remaining supplies, stretching the weekly injections to 10 days, two weeks, even three weeks